Yihan Li
Stock Analyst at Barclays
(2.96)
# 2,681
Out of 4,587 analysts
41
Total ratings
75%
Success rate
16%
Average return
Main Sectors:
Stocks Rated by Yihan Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | €157.20 | +8.14% | 13 | Jul 1, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $86 → $65 | $46.53 | +40.71% | 2 | May 11, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 155.00 | CHF 180.65 | -14.20% | 21 | Dec 8, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 375.00 | kr 332.44 | +12.80% | 2 | Nov 28, 2025 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 275.00 | CHF 353.40 | -22.18% | 3 | Oct 24, 2025 |
Ipsen S.A.
Jul 1, 2026
Maintained: Hold
Price Target: €170.00
Current: €157.20
Upside: +8.14%
Zealand Pharma A/S
May 11, 2026
Maintained: Buy
Price Target: $86 → $65
Current: $46.53
Upside: +40.71%
Galderma Group AG
Dec 8, 2025
Maintained: Buy
Price Target: CHF 155.00
Current: CHF 180.65
Upside: -14.20%
Novo Nordisk A/S
Nov 28, 2025
Maintained: Hold
Price Target: kr 375.00
Current: kr 332.44
Upside: +12.80%
Roche Holding AG
Oct 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: CHF 353.40
Upside: -22.18%